ATE417036T1 - Verbessertes verfahren zur herstellung von 3- hydroxy-4-hydroxymethyl-pyrrolidin-verbindungen - Google Patents

Verbessertes verfahren zur herstellung von 3- hydroxy-4-hydroxymethyl-pyrrolidin-verbindungen

Info

Publication number
ATE417036T1
ATE417036T1 AT05757531T AT05757531T ATE417036T1 AT E417036 T1 ATE417036 T1 AT E417036T1 AT 05757531 T AT05757531 T AT 05757531T AT 05757531 T AT05757531 T AT 05757531T AT E417036 T1 ATE417036 T1 AT E417036T1
Authority
AT
Austria
Prior art keywords
hydroxy
hydroxymethyl
producing
improved method
pyrrolidine compounds
Prior art date
Application number
AT05757531T
Other languages
English (en)
Inventor
Dirk Henning Lenz
Jennifer Mary Mason
Keith Clinch
Gary Brian Evans
Peter Charles Tyler
Original Assignee
Ind Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ind Res Ltd filed Critical Ind Res Ltd
Application granted granted Critical
Publication of ATE417036T1 publication Critical patent/ATE417036T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
AT05757531T 2004-06-04 2005-06-03 Verbessertes verfahren zur herstellung von 3- hydroxy-4-hydroxymethyl-pyrrolidin-verbindungen ATE417036T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NZ533360A NZ533360A (en) 2004-06-04 2004-06-04 Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds

Publications (1)

Publication Number Publication Date
ATE417036T1 true ATE417036T1 (de) 2008-12-15

Family

ID=35462865

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05757531T ATE417036T1 (de) 2004-06-04 2005-06-03 Verbessertes verfahren zur herstellung von 3- hydroxy-4-hydroxymethyl-pyrrolidin-verbindungen

Country Status (20)

Country Link
US (1) US8183019B2 (de)
EP (1) EP1756052B1 (de)
JP (2) JP5219506B2 (de)
KR (1) KR101294732B1 (de)
CN (1) CN101018768B (de)
AT (1) ATE417036T1 (de)
AU (1) AU2005250308B2 (de)
CA (1) CA2568836C (de)
CY (1) CY1108866T1 (de)
DE (1) DE602005011609D1 (de)
DK (1) DK1756052T3 (de)
ES (1) ES2318504T3 (de)
HK (1) HK1106518A1 (de)
IL (1) IL179749A (de)
MX (1) MXPA06014139A (de)
NZ (1) NZ533360A (de)
PL (1) PL1756052T3 (de)
PT (1) PT1756052E (de)
SI (1) SI1756052T1 (de)
WO (1) WO2005118532A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985848A (en) 1997-10-14 1999-11-16 Albert Einstein College Of Medicine Of Yeshiva University Inhibitors of nucleoside metabolism
CA2634299C (en) 1999-04-08 2011-05-31 Industrial Research Limited Process for preparing inhibitors of nucleoside metabolism
EP1539783B1 (de) 2002-08-21 2011-04-13 Albert Einstein College Of Medicine Of Yeshiva University Inhibitoren von nukleosidphosphorylasen und nukleosidasen
NZ523970A (en) * 2003-02-04 2005-02-25 Ind Res Ltd Process for preparing inhibitors of nucleoside phoshorylases and nucleosidases
CN1329374C (zh) * 2004-06-09 2007-08-01 上海靶点药物有限公司 作为ccr5拮抗剂的化合物
AU2006275725A1 (en) * 2005-07-27 2007-02-08 Albert Einstein College Of Medicine Of Yeshiva University Transition state structure of 5'-methylthioadenosine/s-adenosylhomocysteine nucleosidases
NZ544187A (en) * 2005-12-15 2008-07-31 Ind Res Ltd Deazapurine analogs of 1'-aza-l-nucleosides
WO2007097643A1 (en) * 2006-02-22 2007-08-30 Industrial Research Limited Analogues of coformycin and their use for treating protozoan parasite infections
WO2007097647A1 (en) 2006-02-24 2007-08-30 Albert Einstein College Of Medicine Of Yeshiva University Methods of treating cancer
US20110092521A1 (en) * 2006-02-24 2011-04-21 Richard Hubert Furneaux Methods of Treating Diseases Using Inhibitors of Nucleoside Phosphorylases and Nucleosidases
CN101094080B (zh) * 2006-06-22 2012-06-20 华为技术有限公司 一种即按即通系统中的计费方法
PL2057165T3 (pl) * 2006-09-07 2011-08-31 Victoria Link Ltd Acykliczne inhibitory aminowe fosforylaz i hydrolaz nukleozydowych
WO2008030118A1 (en) 2006-09-07 2008-03-13 Industrial Research Limited Acyclic amine inhibitors of 5'-methylthioadenosine phosphorylase and nucleosidase
CN101600711A (zh) * 2006-12-22 2009-12-09 工业研究有限公司 核苷酶和磷酸化酶抑制剂的氮杂环丁烷类似物
US8062870B2 (en) * 2008-01-25 2011-11-22 Xenoport, Inc. Enantiomerically resolving acyloxyalkyl thiocarbonates used in synthesizing acyloxyalkyl carbamate prodrugs
WO2010033236A2 (en) * 2008-09-22 2010-03-25 Albert Einstein College Of Medicine Of Yeshiva University Methods and compositions for treating bacterial infections by inhibiting quorum sensing
EP2454263B1 (de) 2009-07-17 2018-06-13 Albert Einstein College of Medicine, Inc. 3-hydroxypyrrolidinhemmer von 5'-methylthioadenosin-phosphorylase und -nucleosidase
WO2012074912A1 (en) 2010-11-29 2012-06-07 Albert Einstein College Of Medicine Of Yeshiva University Methods, assays and compounds for treating bacterial infections by inhibiting methylthioinosine phosphorylase
WO2014025842A1 (en) 2012-08-07 2014-02-13 Albert Einstein College Of Medicine Of Yeshiva University Treatment of helicobacter pylori infections
US9994574B2 (en) 2012-11-12 2018-06-12 Victoria Link Limited Salt and polymorphic forms of (3R,4S)-L-((4-amino-5H-pyrrolo[3,2,-d]pyrimidin-7-yl)methyl)-4(methylthiomethyl)pyrodin-3-ol(MTDIA)
US10118928B2 (en) 2014-02-12 2018-11-06 Albert Einstein College Of Medicine, Inc. Treatment of H. pylori infections using MTAN inhibitors
CN104529814A (zh) * 2014-12-15 2015-04-22 上海同昌生物医药科技有限公司 一种合成n-苄基羟胺盐酸盐的方法
CN111793017B (zh) * 2019-04-04 2024-01-16 广东东阳光药业股份有限公司 一种内酰胺化合物的制备方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3504026B2 (ja) 1995-06-16 2004-03-08 株式会社トクヤマ ピロリジン誘導体の製造方法
US6379911B2 (en) 1996-02-23 2002-04-30 Albert Einstein College Of Medicine Of Yeshiva University Enzyme detection/assay method and substrates
US5985848A (en) 1997-10-14 1999-11-16 Albert Einstein College Of Medicine Of Yeshiva University Inhibitors of nucleoside metabolism
US6239163B1 (en) 1999-03-15 2001-05-29 Novo Nordisk A/S Salt of (2R,3R,4R)-3,4-dihydroxy-2-hydroxymethylpyrrolidine
DE60022172D1 (de) 1999-03-15 2005-09-29 Novo Nordisk As Salz des (2r,3r,4r)3,4-dihydroxy-2-hydroxymethylpyrrolidins
CA2634299C (en) 1999-04-08 2011-05-31 Industrial Research Limited Process for preparing inhibitors of nucleoside metabolism
US6448799B1 (en) * 1999-09-30 2002-09-10 Hitachi Electronics Engineering Co., Ltd. Timing adjustment method and apparatus for semiconductor IC tester
JP2004507534A (ja) 2000-08-29 2004-03-11 インダストリアル　リサーチ　リミテッド ヌクレオシド代謝阻害剤
US6458799B1 (en) 2000-08-31 2002-10-01 Biocryst Pharmaceuticals, Inc. Deazaguanine analog, preparation thereof and use thereof
EP1486500B1 (de) * 2002-03-18 2009-09-16 Kyorin Pharmaceutical Co., Ltd. 10-(3-cyclo propyl amino methyl-1-pyrrolidinyl) pyridobenzoxazin carbonsäure derivat mit wirkung gegen resistente bakterien
US7098334B2 (en) 2002-03-25 2006-08-29 Industrial Research Limited 4-amino-5H-pyrrolo[3,2-d]pyrimidine inhibitors of nucleoside phosphorylases and nucleosidases
EP1539783B1 (de) 2002-08-21 2011-04-13 Albert Einstein College Of Medicine Of Yeshiva University Inhibitoren von nukleosidphosphorylasen und nukleosidasen
NZ523970A (en) 2003-02-04 2005-02-25 Ind Res Ltd Process for preparing inhibitors of nucleoside phoshorylases and nucleosidases
US20060216775A1 (en) 2003-06-17 2006-09-28 The Regents Of The University Of Califoenia Compositions and methods for analysis and manipulation of enzymes in biosynthetic proteomes
CA2538169A1 (en) * 2003-09-09 2005-03-17 Albert Einstein College Of Medicine Of Yeshiva University Transition state analog inhibitors of ricin a-chain
CN1329374C (zh) 2004-06-09 2007-08-01 上海靶点药物有限公司 作为ccr5拮抗剂的化合物
EP1771452A4 (de) 2004-07-27 2009-07-15 Biocryst Pharm Inc 5'-methylthioadenosin-phosphorylase- und 5'methylthioadenosin-/s-adenosylhomocystein-nucleosidase-hemmer
NZ540160A (en) 2005-05-20 2008-03-28 Einstein Coll Med Inhibitors of nucleoside phosphorylases
AU2006275725A1 (en) 2005-07-27 2007-02-08 Albert Einstein College Of Medicine Of Yeshiva University Transition state structure of 5'-methylthioadenosine/s-adenosylhomocysteine nucleosidases
NZ544187A (en) 2005-12-15 2008-07-31 Ind Res Ltd Deazapurine analogs of 1'-aza-l-nucleosides
US20110092521A1 (en) 2006-02-24 2011-04-21 Richard Hubert Furneaux Methods of Treating Diseases Using Inhibitors of Nucleoside Phosphorylases and Nucleosidases
WO2007097647A1 (en) 2006-02-24 2007-08-30 Albert Einstein College Of Medicine Of Yeshiva University Methods of treating cancer
WO2007144780A2 (en) * 2006-03-29 2007-12-21 Medichem S.A. Processes for preparing ezetimibe and intermediate compounds useful for the preparation thereof
PL2057165T3 (pl) 2006-09-07 2011-08-31 Victoria Link Ltd Acykliczne inhibitory aminowe fosforylaz i hydrolaz nukleozydowych
WO2008030118A1 (en) 2006-09-07 2008-03-13 Industrial Research Limited Acyclic amine inhibitors of 5'-methylthioadenosine phosphorylase and nucleosidase
AU2007300624A1 (en) 2006-09-26 2008-04-03 Albert Einstein College Of Medicine Of Yeshiva University Transition state structure of human 5'-methylthioadenosine phosphorylase
CN101600711A (zh) 2006-12-22 2009-12-09 工业研究有限公司 核苷酶和磷酸化酶抑制剂的氮杂环丁烷类似物
WO2009082247A1 (en) 2007-12-21 2009-07-02 Industrial Research Limited Process for preparing immucillins having a methylene link
WO2010033236A2 (en) 2008-09-22 2010-03-25 Albert Einstein College Of Medicine Of Yeshiva University Methods and compositions for treating bacterial infections by inhibiting quorum sensing
EP2454263B1 (de) 2009-07-17 2018-06-13 Albert Einstein College of Medicine, Inc. 3-hydroxypyrrolidinhemmer von 5'-methylthioadenosin-phosphorylase und -nucleosidase

Also Published As

Publication number Publication date
US8183019B2 (en) 2012-05-22
EP1756052A1 (de) 2007-02-28
JP2008501682A (ja) 2008-01-24
CY1108866T1 (el) 2014-07-02
CA2568836C (en) 2013-04-16
DE602005011609D1 (de) 2009-01-22
CN101018768A (zh) 2007-08-15
JP2012211136A (ja) 2012-11-01
CN101018768B (zh) 2012-11-21
US20080280334A1 (en) 2008-11-13
HK1106518A1 (en) 2008-03-14
EP1756052B1 (de) 2008-12-10
DK1756052T3 (da) 2009-03-09
AU2005250308B2 (en) 2012-04-26
NZ533360A (en) 2007-02-23
EP1756052A4 (de) 2007-08-22
IL179749A (en) 2011-07-31
MXPA06014139A (es) 2007-05-09
IL179749A0 (en) 2007-05-15
AU2005250308A1 (en) 2005-12-15
CA2568836A1 (en) 2005-12-15
KR101294732B1 (ko) 2013-08-12
WO2005118532A1 (en) 2005-12-15
ES2318504T3 (es) 2009-05-01
JP5219506B2 (ja) 2013-06-26
PL1756052T3 (pl) 2009-05-29
PT1756052E (pt) 2009-02-11
SI1756052T1 (sl) 2009-04-30
KR20070050037A (ko) 2007-05-14

Similar Documents

Publication Publication Date Title
ATE417036T1 (de) Verbessertes verfahren zur herstellung von 3- hydroxy-4-hydroxymethyl-pyrrolidin-verbindungen
DE602006021411D1 (de) Verfahren zur herstellung von optional 2-substituierten 1,6-dihydro-6-oxo-4-pyrimidincarboxylsäuren
ATE453622T1 (de) Verfahren zur herstellung von enantiomeren angereicherten cyclischen beta-aryl- oder heteroarylcarbonsäuren
ATE424392T1 (de) Verfahren zur herstellung von enantiomerenreinen aminoalkoholen
ATE440815T1 (de) Verfahren zur herstellung von dialkylcarbonaten
ATE489352T1 (de) Verfahren zur herstellung von brenztraubensäure
ATE466015T1 (de) Verfahren zur herstellung von phenserin und dessen analogon
ATE437869T1 (de) Verfahren zur herstellung von pyridinylmethyl-1h- benzimidazolverbindungen in enantiomerenangereicherter form oder als einzelne enantiomere
ATE407130T1 (de) Verfahren zur herstellung von 2- azetidinonderivaten
WO2006034812A3 (de) Verfahren zur herstellung von optisch aktiven 2-methylalkan-1-ols aus dem entsprechenden 2-methylalk-2-en-1-al, umfassend eine carbonylselektive reduktion, eine enantioselektive hydrierung und eine lipase-katalysierte, stereoselektive acylierung zwecks anreicherung des gewünschten enatiomers
ATE457356T1 (de) Verfahren zur herstellung von vorwiegend ein enantiomer enthaltendes 1,1,1-trifluorisopropanol
ATE281434T1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
ATE459723T1 (de) Verfahren zur herstellung von (4s)-3,4-dihydroxy- 2,6,6-trimethyl-cyclohex-2-enon und derivaten davon unter verwendung der azoarcus phenylethanol dehydrogenase
ATE427306T1 (de) Verfahren zur herstellung von escitalopram
ATE368661T1 (de) Verfahren zur herstellung von 5-(4-fluorphenyl)-1- 2-((2r,4r)-4-hydroxy-6-oxo etrahydropyran-2- yl)ethylö-2-isopropyl-4-phenyl-1h-pyrrol-3- carbonsäurephenylamid
ATE370950T1 (de) Verfahren zur herstellung von (1s,4r)-cis-4-(2- amino-6-chlor-9h-purin-9-yl)-2-cyclopenten-1- methanol
DE602005013007D1 (de) Verfahren zur herstellung von lactonen
GB0417063D0 (en) Process for the preparation of optically-active compounds
DE602004006021D1 (de) Verfahren zur racematspaltung von nefopam
DE602004030091D1 (de) Verfahren zur reduktiven deshalogenierung
ATE439333T1 (de) Verfahren zur herstellung optisch aktiver propoxyanilinderivate
ATE375355T1 (de) Verfahren zur herstellung von cefpodoxim-proxetil
DE502005003019D1 (de) Verfahren zur herstellung der enantiomeren formen von 2,3-diaminopropionsäurederivaten
ATE525357T1 (de) Verfahren zur herstellung von cyclohexandiessigsäuremonoamid
ATE485387T1 (de) Verfahren zur herstellung enantioreiner beta- aminosäurederivate sowie enantioreine beta- aminosäurederivate

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1756052

Country of ref document: EP